𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Suramin treatment for chronic active hepatitis B—toxic and ineffective

✍ Scribed by R. H. T. Loke; M. G. Anderson; J. C. Coleman; Dr. I. M. Murray-Lyon; K. N. Tsiquaye; A. J. Zuckerman

Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
198 KB
Volume
21
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis

Suramin has recently been shown to inhibit the activity of the duck hepatitis B virus DNA polymerase (DHBV DNAp) in vitro.

However, we found no demonstrable in vivo suppression of human hepatitis B virus DNA polymerase (HBV DNAp) activity in three male patients with severe chronic active hepatitis. Suramin treatment resulted in prolongation of the prothrombin time in all cases and a rise in bilirubin in two and it may have led to haemorrhage from oesophageal varices in one patient and to hepatic encephalopathy in another. Its use in chronic hepatitis is not recommended.

📜 SIMILAR VOLUMES

Long-term efficacy and safety of adefovi
Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B
✍ Patrick Marcellin; Ting-Tsung Chang; Seng G. Lee Lim; William Sievert; Myron Ton 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 1 views

Treatment of 171 patients with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) with adefovir dipivoxil (ADV) 10 mg over 48 weeks resulted in significant histological, virological, serological, and biochemical improvement compared with placebo. The long-term efficacy and safety of AD

Treatment of chronic type B hepatitis wi
Treatment of chronic type B hepatitis with recombinant α-interferon induces autoantibodies not specific for autoimmune chronic hepatitis
✍ Werner-J. Mayet; Georg Hess; Guido Gerken; Siegbert Rossol; Rita Voth; Michael M 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB 👁 1 views

Recombinant human a-interferon is now under intensive investigation as therapy for chronic Type B hepatitis. Recent reports have suggested that prolonged a- interferon therapy may induce autoimmune reactions. We have evaluated the problem of autoimmunity related to a-interferon therapy by testing fo